510 related articles for article (PubMed ID: 17697860)
21. Lipid abnormalities in coronary heart disease: a population-based case-control study.
Gupta R; Kaul V; Prakash H; Sarna M; Singhal S; Gupta VP
Indian Heart J; 2001; 53(3):332-6. PubMed ID: 11516034
[TBL] [Abstract][Full Text] [Related]
22. Lipoprotein(a) in South Indian type 2 diabetic subjects in relation to diabetic vascular complications.
Deepa R; Mohan A; Rema M; Haranath SP; Saravanan G; Mohan V
J Assoc Physicians India; 2002 May; 50(5):657-61. PubMed ID: 12186119
[TBL] [Abstract][Full Text] [Related]
23. The importance of Lp(a)-fibronectin interaction in atherogenesis.
Sönmez H; Süer S; Kökoğlu E; Dirican A; Ulutin T; Uçişik N; Ulutin ON
Haematologia (Budap); 1997; 28(3):149-53. PubMed ID: 9283915
[TBL] [Abstract][Full Text] [Related]
24. [Homocysteine, lipoprotein (a): risk factors for coronary heart disease].
Laraqui A; Bennouar N; Meggouh F; Allami A; El Kadiri N; Benkouka F; Azeddoug H; El Haitem N; Benomar A; Fellat S; Benomar M
Ann Biol Clin (Paris); 2002; 60(5):549-57. PubMed ID: 12368140
[TBL] [Abstract][Full Text] [Related]
25. [Lp(a) serum concentrations in diabetes mellitus].
Murakami J; Kumasaka K; Kawano K; Murakami T; Hayashi Y; Arakawa Y
Rinsho Byori; 1994 Dec; 42(12):1273-8. PubMed ID: 7869592
[TBL] [Abstract][Full Text] [Related]
26. Serum lipoprotein (a) level and restenosis after percutaneous coronary intervention.
Lolekha P; Leowattana W; Kangkagate C; Mahanonda N; Pokum S
J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S628-35. PubMed ID: 12002903
[TBL] [Abstract][Full Text] [Related]
27. Lipoprotein(a) in coronary heart disease: a case-control study.
Gupta R; Kastia S; Rastogi S; Kaul V; Nagar R; Enas EA
Indian Heart J; 2000; 52(4):407-10. PubMed ID: 11084780
[TBL] [Abstract][Full Text] [Related]
28. The relationship between lipoprotein(a) and the complications of diabetes mellitus.
Koschinsky ML; Marcovina SM
Acta Diabetol; 2003 Jun; 40(2):65-76. PubMed ID: 12861403
[TBL] [Abstract][Full Text] [Related]
29. Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier?
Shai I; Rimm EB; Hankinson SE; Cannuscio C; Curhan G; Manson JE; Rifai N; Stampfer MJ; Ma J
Eur Heart J; 2005 Aug; 26(16):1633-9. PubMed ID: 15824077
[TBL] [Abstract][Full Text] [Related]
30. [Lipoprotein (a). A new risk factor for coronary artery disease].
Rim L; Ali B; Slim BA; Bechir Z
Tunis Med; 2000 Nov; 78(11):648-52. PubMed ID: 11155388
[TBL] [Abstract][Full Text] [Related]
31. Lipoprotein (a) as a determinant of arterial stiffness in elderly patients with type 2 diabetes mellitus.
Wakabayashi I; Masuda H
Clin Chim Acta; 2006 Nov; 373(1-2):127-31. PubMed ID: 16820145
[TBL] [Abstract][Full Text] [Related]
32. Inherited dyslipidaemic disorders contributing to coronary heart disease.
Attaullah S; Bangash R; Amanullah ; Ahmed Z; Rehman J
J Ayub Med Coll Abbottabad; 2008; 20(4):90-3. PubMed ID: 19999214
[TBL] [Abstract][Full Text] [Related]
33. Lipoprotein(a) determination and risk of cardiovascular disease in South African patients with familial hypercholesterolaemia.
Scholtz CL; Lingenhel A; Hillermann R; Stander IA; Kriek JA; Marais MP; Odendaal HJ; Kraft HG; Utermann G; Kotze MJ
S Afr Med J; 2000 Apr; 90(4):374-8. PubMed ID: 10957922
[TBL] [Abstract][Full Text] [Related]
34. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
Wanner C; Bartens W; Nauck M; Zäuner I; Greiber S; Schollmeyer P
Miner Electrolyte Metab; 1996; 22(1-3):26-30. PubMed ID: 8676820
[TBL] [Abstract][Full Text] [Related]
35. Segregation analysis of plasma lipoprotein(a) levels in pedigrees with molecularly defined familial hypercholesterolemia.
Friedlander Y; Leitersdorf E
Genet Epidemiol; 1995; 12(2):129-43. PubMed ID: 7607414
[TBL] [Abstract][Full Text] [Related]
36. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study.
Bruce IN; Urowitz MB; Gladman DD; Ibañez D; Steiner G
Arthritis Rheum; 2003 Nov; 48(11):3159-67. PubMed ID: 14613278
[TBL] [Abstract][Full Text] [Related]
38. [Lipoprotein(a): genetic marker of precocious myocardial infarction].
Guazzelli R; Fatini C; Piazzini M; Lazzeri C
Ann Ital Med Int; 1996; 11(2):90-4. PubMed ID: 8974444
[TBL] [Abstract][Full Text] [Related]
39. Lipoprotein(a), fibrinogen and vascular mortality in an elderly northern Italian population.
D'Angelo A; Ruotolo G; Garancini P; Sampietro F; Mazzola G; Calori G
Haematologica; 2006 Dec; 91(12):1613-20. PubMed ID: 17145597
[TBL] [Abstract][Full Text] [Related]
40. Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort.
Athyros VG; Liberopoulos EN; Mikhailidis DP; Papageorgiou AA; Ganotakis ES; Tziomalos K; Kakafika AI; Karagiannis A; Lambropoulos S; Elisaf M
Angiology; 2007 Dec-2008 Jan; 58(6):689-97. PubMed ID: 18216378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
